Follow The Filings

ROIV position history

The shares of Roivant Sciences (ROIV) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.

Equity, SHS

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q4: 176,477,400 shares, $1.8B, 5.1% of portfolio, New
  2. 2022 Q1: 88,238,700 shares, $436M, 1.8% of portfolio, Reduce −50.0%
  3. 2022 Q2: 88,238,700 shares, $359M, 1.6% of portfolio
  4. 2022 Q3: 88,238,700 shares, $284M, 1.3% of portfolio
  5. 2022 Q4: 88,238,700 shares, $705M, 3.5% of portfolio
  6. 2023 Q1: 88,238,700 shares, $651M, 3.1% of portfolio
  7. 2023 Q2: 75,238,700 shares, $758M, 3.1% of portfolio, Reduce −14.7%
  8. 2023 Q3: 73,434,301 shares, $858M, 3.5% of portfolio, Reduce −2.4%
  9. 2023 Q4: 69,368,961 shares, $779M, 2.9% of portfolio, Reduce −5.5%
  10. 2024 Q1: 69,368,961 shares, $731M, 2.7% of portfolio
  11. 2024 Q2: 69,155,846 shares, $731M, 2.8% of portfolio, Reduce −0.3%
  12. 2024 Q3: 54,099,066 shares, $624M, 2.3% of portfolio, Reduce −21.8%
  13. 2024 Q4: 47,809,960 shares, $566M, 1.8% of portfolio, Reduce −11.6%
  14. 2025 Q1: 46,013,752 shares, $464M, 1.5% of portfolio, Reduce −3.8%
  15. 2025 Q2: 34,237,779 shares, $386M, 1.1% of portfolio, Reduce −25.6%
  16. 2025 Q3: 23,594,831 shares, $357M, 0.93% of portfolio, Reduce −31.1%
  17. 2025 Q4: 6,443,191 shares, $140M, 0.37% of portfolio, Reduce −72.7%
  18. 2026 Q1: 6,652,448 shares, $184M, 0.52% of portfolio, Add +3.2%
  19. 2026 Q2: 6,271,467 shares, $222M, 0.63% of portfolio, Reduce −5.7%
  20. 2026 Q3: 6,757,326 shares, $247M, 0.76% of portfolio, Add +7.7%
Holdings date Value % of holdings Shares Filing date All 13F holders